Prognose

Für dieses Unternehmen liegen uns keine Analysten-Daten vor.

Scoring-Modelle

Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.

Beliebteste Broker

News

Entourage Health to Host Third Quarter 2024 Earnings Conference Call
TORONTO, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning cannabis products, announced today that the Company's third quarter 2024 financial results will be released after market close on Thursday, November 28, 2024. The Company will host a conference call to discuss these results and provide an operational update and recap of achievements on Friday, November 29, 2024.» Mehr auf globenewswire.com
Entourage Health Provides Company Update
TORONTO, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning cannabis products, announced earlier it was in breach of certain financial covenants and other obligations under each of its Senior Credit Agreement and Subordinated Credit agreements with an affiliate of the LiUNA Pension Fund of Central and Eastern Canada (“LPF”). The Company is working collaboratively with LPF to agree on amended debt terms. As a positive step forward, the Company received a renewed forbearance letter dated October 31, 2024, waiving the Company's breaches until November 29, 2024, subject to the satisfaction or waiver of certain conditions.» Mehr auf globenewswire.com
Entourage Health Increases Senior Secured Credit Facility
TORONTO, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE: 4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning cannabis products, confirmed today it has signed an amendment (the "Amendment") to its senior secured amended and restated credit facility entered into on January 31, 2023 (the "Credit Facility") with an affiliate of the LiUNA Pension Fund of Central and Eastern Canada ("LPF").» Mehr auf globenewswire.com

Unternehmenszahlen

Im letzten Quartal hatte Entourage Health einen Umsatz von 6,31 Mio€ und ein Nettoeinkommen von −7,03 Mio€

(EUR)	Juni 2024	YOY
Umsatz	+6,31 Mio	10,31%
Bruttoeinkommen	+812,84k	61,57%
Nettoeinkommen	−7,03 Mio	6,26%
EBITDA	−2,32 Mio	35,60%

Fundamentaldaten

Metrik	Wert
Marktkapitalisierung	+1,19 Mio€
Anzahl Aktien	308,39 Mio
52 Wochen-Hoch/Tief	+0,0147€ - +0,00202€
Dividenden	Nein
Beta	1,06
KGV (PE Ratio)	−0,07
KGWV (PEG Ratio)	0,00
KBV (PB Ratio)	−0,02
KUV (PS Ratio)	+0,08

Unternehmensprofil

Entourage Health Corp. beschäftigt sich mit der Produktion und dem Vertrieb von Cannabisprodukten für den medizinischen und den Erwachsenenmarkt in Kanada. Das Unternehmen bietet Cannabispflanzen, getrocknetes Cannabis, Öle, topische Produkte, Extrakte und Esswaren an. Es bietet seine Produkte unter den Markennamen Color Cannabis, Saturday Cannabis, Starseed Medicinals und Mary's Medicinals an. Das Unternehmen war früher als WeedMD Inc. bekannt und änderte im Juli 2021 seinen Namen in Entourage Health Corp. um. Der Hauptsitz von Entourage Health Corp. befindet sich in Toronto, Kanada.